Different regulatory roles have been described for the miR-182, including cell growth, cancer progression, lymphocyte expansion, and even positive regulation of osteoclastogenesis via the miR-182-PKR-IFN-β pathway [63]. This evidence concerns the gene IFNB1 and cancer.